Synthesis and antitumor activity evaluation of new 2-(4-aminophenyl)benzothiazole derivatives bearing different heterocyclic rings

References

• Hu W-P, Chen Y-K, Liao C-C, et al. Synthesis, and biological evaluation of 2-(4-aminophenyl)benzothiazole derivatives as photosensitizing agents. Bioorg Med Chem 2010;18:6197–207
   PubMed Web of Science ®Google Scholar
• Choi S-J, Park HJ, Lee SK, et al. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity. Bioorg Med Chem 2006;14:1229–35
   PubMed Web of Science ®Google Scholar
• Novak M, Chakraborty M. Reactions of a putative metabolite of the model antitumor drug 2-(4-aminophenyl) benzothiazole with purines and pyrimidines. J Phys Org Chem 2011;24:960–8
   Web of Science ®Google Scholar
• Tasler S, Müller O, Wieber T, et al. N-substituted 2′-(aminoaryl)benzothiazoles as kinase inhibitors: hit identification and scaffold hopping. Bioorg Med Chem Lett 2009;19:1349–56
   PubMed Web of Science ®Google Scholar
• Shi D-F, Bradshaw TD, Wrigley S, et al. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 1996;39:3375–84
   PubMed Web of Science ®Google Scholar
• Tzanopoulou S, Pirmettis IC, Patsis G, et al. Synthesis, characterization, and biological evaluation of M(I)(CO)3(NNO) complexes (M) Re, 99mTc) conjugated to 2-(4-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem 2006;49:5408–10
   PubMed Web of Science ®Google Scholar
• Hutchinson I, Bradshaw TD, Matthews CS, et al. Antitumour benzothiazoles. Part 20: 3′-Cyano and 3′-alkynyl-substituted 2-(4′-aminophenyl)benzothiazoles as new potent and selective analogues. Bioorg Med Chem Lett 2003;13:471–4
   PubMed Web of Science ®Google Scholar
• Bradshaw TD, Wrigley S, Shi D-F, et al. 2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity. Brit J Cancer 1998;77:745–52
   PubMed Web of Science ®Google Scholar
• Chua M-S, Shi D-F, Wrigley S, et al. Antitumor benzothiazoles. 7. Synthesis of 2-(4-acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumor activities of the parent amines. J Med Chem 1999;42:381–92
   PubMed Web of Science ®Google Scholar
• Bradshaw TD, Shi D-F, Schultz RJ, et al. Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo. Brit J Cancer 1998;78:421–9
   PubMed Web of Science ®Google Scholar
• Kashiyama E, Hutchinson I, Chua M-S, et al. Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles. J Med Chem 1999;42:4172–84
   PubMed Web of Science ®Google Scholar
• Bradshaw TD, Stevens MFG, Westwell AD. The discovery of the potent and selective antitumour agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) and related compounds. Curr Med Chem 2001;8:203–10
   PubMed Web of Science ®Google Scholar
• Shi D-F, Bradshaw TD, Chua M-S, et al. Antitumour benzothiazoles. Part 15: The synthesis and physicochemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives. Bioorg Med Chem Lett 2011;11:1093–5
   Google Scholar
• Leong C-O, Gaskell M, Martin EA, et al. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo. Brit J Cancer 2003;88:470–7
   PubMed Web of Science ®Google Scholar
• Hutchinson I, Jennings SA, Vishnuvajjala BR, et al. Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. J Med Chem 2002;45:744–7
   PubMed Web of Science ®Google Scholar
• Mortimer CG, Wells G, Crochard J-P, et al. Antitumor benzothiazoles. 26.1 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J Med Chem 2006;49:179–85
   PubMed Web of Science ®Google Scholar
• Chakraborty M, Jin KJ, Glover SA, Novak M. Characterization of the 4-(benzothiazol-2-yl)phenylnitrenium ion from a putative metabolite of a model antitumor drug. J Org Chem 2010;75:5296–304
   PubMed Web of Science ®Google Scholar
• Racane L, Tralic-Kulenovic V, Kitson RP, Karminski-Zamola G. Synthesis and antiproliferative activity of cyano and amidino substituted 2-phenylbenzothiazoles. Monatsh Chem 2006;137:1571–7
   Web of Science ®Google Scholar
• Racane L, Stojkovic R, Tralic-Kulenovic V, Karminski-Zamola G. Synthesis and antitumor evaluation of novel derivatives of 6-amino-2-phenylbenzothiazoles. Molecules 2006;11:325–33
   PubMed Web of Science ®Google Scholar
• Bradshaw TD, Westwell AD. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr Med Chem 2004;11:1241–53
   Google Scholar
• Brantley E, Trapani V, Alley MC, et al. Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells. Drug Metab Dispos 2004;32:1392–401
   PubMed Web of Science ®Google Scholar
• Hutchinson I, Chua M-S, Browne HL, et al. Antitumor benzothiazoles. 14.1 Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. J Med Chem 2001;44:1446–55
   PubMed Web of Science ®Google Scholar
• Tzanopoulou S, Sagnou M, Paravatou-Petsotas M, et al. Evaluation of Re and (99m)Tc complexes of 2-(4′-aminophenyl)benzothiazole as potential breast cancer radiopharmaceuticals. J Med Chem 2010;53:4633–41
   PubMed Web of Science ®Google Scholar
• Fichtner I, Monks A, Hose C, et al. The experimental antitumor agents Phortress and Doxorubicin are equiactive against human-derived breast carcinoma xenograft models. Breast Cancer Res Tr 2004;87:97–107
   PubMed Web of Science ®Google Scholar
• Kamal A, Reddy KS, Khan MNA, et al. Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole–pyrrolo[2,1-c][1,4]benzodiazepine conjugates. Bioorg Med Chem 2010;18:4747–61
   PubMed Web of Science ®Google Scholar
• Racane L, Tralic-Kulenovic V, Pavelic SK, et al. Novel diamidino-substituted derivatives of phenyl benzothiazolyl and dibenzothiazolyl furans and thiophenes: synthesis, antiproliferative and DNA binding properties. J Med Chem 2010;53:2418–32
   PubMed Web of Science ®Google Scholar
• Tay F, Yurttaş L, Demirayak Ş. Synthesis of some N-[4-(benzothiazole-2yl) phenyl]-2-aryloxyacetamide derivatives and their anticancer activities. J Enzyme Inhib Med Chem 2012;27:515–20
   PubMed Web of Science ®Google Scholar
• Boyd MR. Status of the NCI preclinical antitumor drug discovery screen. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology updates, vol. 3, no. 10. Philadelphia: JPLippincott; 1989:1–12
   Google Scholar